FDA 483 OBSERVATION · #151 OF 1,945 MOST-CITED

Written procedures - returned dietary supplement

FDA cited this observation 206 times across 198 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods206
BY FISCAL YEAR
FY202421
FY202323
FY202226
FY20217
FY202010
FY201925
FY201832
FY201741
FY201621

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 3× the rate of the average FDA-cited firm (23.7% vs 7.8%), across 198 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

You did not establish and follow written procedures for when a returned dietary supplement is received.

Wholly Liquid Nutritional Supplements LLC · Hampton, New Hampshire · Foods · 2024-06-27

You did not establish written procedures for when a returned dietary supplement is received.

Sun Breeze Inc · Central Point, Oregon · Foods · 2024-06-21

You did not establish written procedures for when a returned dietary supplement is received.

Pinnacle Labs International, Inc. · Upland, California · Foods · 2024-06-14

You did not establish written procedures for when a returned dietary supplement is received.

R. Day Enterprises, Inc. · Upland, California · Foods · 2024-06-14

You did not establish written procedures for when a returned dietary supplement is received.

Nutra Group LLC · Lake Ronkonkoma, New York · Foods · 2024-06-10

You did not establish and follow written procedures for when a returned dietary supplement is received.

World Green Nutrition Inc. · San Antonio, Texas · Foods · 2024-05-09

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality system →Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →